Advertisement

Topics

Latest "Standard & Poor’s" News Stories - Page: 4

11:10 EDT 26th April 2018 | BioPortfolio

Here are the most relevant search results for "Standard & Poor’s" found in our extensive news archives from over 250 global news sources.

More Information about Standard & Poor’s on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Standard & Poor’s for you to read. Along with our medical data and news we also list Standard & Poor’s Clinical Trials, which are updated daily. BioPortfolio also has a large database of Standard & Poor’s Companies for you to search.

Showing "Standard Poor" News Articles 76–100 of 3,200+

Monday 23rd April 2018

Prothena Discontinues Development of NEOD001 for AL Amyloidosis

Phase 2b PRONTO study did not meet its primary or secondary endpoints Phase 3 VITAL Amyloidosis Study being discontinued based on futility analysis Investor conference call and webcast today at 8:30 AM ET DUBLIN, Ireland, April 23, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel ther...


Cintas Corporation Tackles Food Waste in Support of Green Umbrella Campaign

Approximately 40 percent of all food produced in the U.S. annually is wasted and ends up in landfills. With Stop Food Waste Day approaching on April 27, Cintas Corporation (NASDAQ: CTAS) has announced its support for

Market Strategies International Achieves HITRUST CSF® Certification to Further Demonstrate Its Commitment to Third Party Privacy, Security & Compliance Standards

Market Strategies International, a leading market research consultancy, announced today that it has earned Certified status for information security by HITRUST. HITRUST CSF Certified status demonstrates that Market Strategies’ Information Systems, including their Unicom Intelligence, MSI Client, and Client portal applications, have met key regul...


EU CAR-T Race Tightens After Yescarta Reverts To Standard Review

Kite and Novartis are vying to be the first company to have a CAR-T therapy approved in the EU. Both...   

Sunspire Health Desert Palms Appoints Henry Bennett as Executive Director

Sunspire Health Desert Palms, a community-based treatment center within Sunspire Health’s nationwide network of addiction treatment facilities offering personalized treatment and addiction recovery services, announced the appointment of Henry Bennett, MHS, as Executive Director.

BIA Head Attacks Rapporteur Reallocation, But Welcomes Further Clarity On Transition Period

Steve Bates, CEO of the BIA, is concerned that the EU authorities are overloading national regulatory agencies by reallocatin...

Magnetic 3D Cell Culture Products from Greiner Bio-One Validated for Use as an Ex Vivo Pancreatic Tumor Model for High Throughput Cancer Drug Screening

Greiner Bio-One North America, Inc. is announcing the publication in SLAS Discovery of an article titled “Advanced Development of Primary Pancreatic Organoid Tumor Models for High Throughput Phenotypic Drug Screening.” Authored by The Scripps Research Institute in Florida, in collaboration with Cold Spring Harbor Laboratory, Greiner Bio-One, Nan...

Shockwave Unveils New Intravascular Lithotripsy Catheter for Calcified Below-the-Knee Peripheral Artery Disease in Europe

Designed Specifically to Address Challenges of Critical Limb Ischemia, the Shockwave S4 Catheter Expands the IVL System Portfolio FREMONT, Calif. (PRWEB) April 23, 2018 Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced CE Mark and European commercial availability of the Shockwave S4 Peripheral Intravascular Lithotripsy (IVL) Catheter. Shockwave S4 ...

Lumendi Receives FDA 510(k) Clearance for Dilumen C2™

Second Generation Endoscopic Accessory for Endolumenal Procedures Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) has announced it has received United States Food and Drug Administration (FDA) 510(k) clearance for the DiLumen C2, its second-generation endoscopic accessory

Pfizer Provides Update on Proposed Trastuzumab Biosimilar

Pfizer Inc. (NYSE:PFE) today announced that it received a Complete Response Letter (CRL) from the United States Food and Drug Administration (FDA) in response to the Biologics License Application for the company’s proposed trastuzumab biosimilar. In the CRL, the FDA highlighted the need for additional technical information. The additional requested infor...

Targeted radiotherapy found to be a good option for women with early breast cancer

Quality of life for women treated with a more targeted radiotherapy treatment - called accelerated partial breast irradiation - is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology.

Paragonix Technologies Inc., Announces Presentation of the Paragonix SherpaPak™ Cardiac Transport System at the 98th Annual Meeting of the American Association of Thoracic Surgeons in San Diego, April 28- May 1, 2018

Paragonix Technologies, Inc. will present the Paragonix SherpaPak™ Cardiac Transport System product line at Booth 340 during the 98th Annual Meeting of the American Association of Thoracic Surgeons (AATS) held in San Diego, from April 28 to May 1, 2018. The Paragonix SherpaPak™ Cardiac Transport System product line1,2 combines innovative cooling techno...

Vizient Launches Cybersecurity Task Force to Address Medical Device Safety

In June 2017, the U.S. Department of Health and Human Services’ Health Care Industry Cybersecurity Task Force issued a report to Congress stating “Health care cybersecurity is in critical condition.” In an effort to harmonize the work being done in hospitals and by device manufacturers to address medical device vulnerabilities,

British Breast Cancer Company, Endomag, Wins Queen’s Award - UK company providing more accurate tools for breast cancer removal receives prestigious business award

Cambridge, UK, 21 April 2018: Endomag, the surgical guidance company, today announced it has received the Queen’s Award for Enterprise in Innovation for 2018. The Award recognises the Company’s efforts in developing novel surgical tools for more accurate removal of breast cancer. Endomag has developed a minimally invasive surgical guidance system, using its expertise in magnetic...

MOLOGEN AG: Announcement of the new dates for the publication of the Annual Financial Statements 2017 and the 2018 Annual General Meeting

DGAP-News: MOLOGEN AG / Key word(s): Miscellaneous 23.04.2018 / 08:57 The issuer is solely responsible for the content of this announcement. PRESS RELEASE N 10 / 2018 of 23/04/2018 MOLOGEN AG: Announcement of the new dates for the publication of the Annual Financial Statements 2017 and the 2018 Annual General Meeting Berlin, 23 April 2018 - The biopharmaceutical company MOLOGEN AG ann...

Trinity Health to Expand Diabetes Prevention with $7 Million from CDC

Trinity Health will connect the people in its communities most at risk for developing Type 2 diabetes with resources for preventing the disease through a five-year, $7 million cooperative agreement from the Centers for Disease Control and Prevention. LIVONIA, Mich. (PRWEB) April 23, 2018 Trinity Health will connect the people in its communities most at risk for developing Type 2 diabetes with res...

Sunday 22nd April 2018

Medical News Today: Diabetes: Body fat percentage, not BMI, predicts risk

A new study suggests that the standard body mass index cannot accurately predict someone's risk of developing type 2 diabetes or prediabetes.

Fresenius SE & Co. KGaA: Fresenius terminates merger agreement with Akorn

Fresenius SE & Co. KGaA / Key word(s): Mergers & Acquisitions Fresenius SE & Co. KGaA: Fresenius terminates merger agreement with Akorn 22-Apr-2018 / 19:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Freseni...

Fresenius Medical Care AG & Co. KGaA adjusts its 2018 revenue growth target and confirms its net income growth target

Fresenius Medical Care AG & Co. KGaA / Key word(s): Change in Forecast Fresenius Medical Care AG & Co. KGaA adjusts its 2018 revenue growth target and confirms its net income growth target 22-Apr-2018 / 16:52 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely respons...

[Review] Current approach of the axilla in patients with early-stage breast cancer

The surgical approach of the axilla in patients with early-stage breast cancer has witnessed considerable evolution during the past 25 years. The previously undisputed gold standard of axillary-lymph-node dissection for staging has now been replaced by sentinel-lymph-node biopsy for patients with clinically negative axilla. For selected patients with limited sentinel-lymph-node involvement, comple...

Heart patients who walk faster hospitalised less – Business Standard

IANSHeart patients who walk faster hospitalised lessBusiness StandardHappy feet, happy heart Slow walking heart patients are hospitalized more Even one cigarette a day ups heart disease, stroke risk: study Daily exercise may help people with heart disease in family New blood test to identify people at heart disease risk ...Faster walking heart patients are hospitalized lessScience DailyWalking fas...

Saturday 21st April 2018

Addition precautions at hospital don't help prevent spread of resistant bacteria

(European Society of Clinical Microbiology and Infectious Diseases) Contact precautions, used in addition to the standard precautions, the basic level of infection control applied to all patients, did not limit or prevent the spread of drug-resistant bacteria in non-intensive care unit (ICU) hospital wards, according to research presented at the 28th European Congress of Clinical Microbiology and ...

Targeted radiotherapy for breast cancer offers good quality of life and fewer side effects

(European Society for Radiotherapy and Oncology (ESTRO)) Quality of life for women treated with a more targeted radiotherapy treatment -- called accelerated partial breast irradiation -- is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology.

Bedside ultrasound is not yet the standard of care. But it will be.

I just read a Clinical Problem Solving case from the New England Journal of Medicine (NEJM). It was entitled “Stream of Consciousness“and it told the story of a 65-year-old man who was a patient at the Brigham and Women’s Hospital of Harvard Medical School, arguably one of the finest medical institutions in the world. These […]

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sells Sound Inpatient Physicians Holdings for $2.15 billion

Fresenius Medical Care AG & Co. KGaA / Key word(s): Disposal/Investment Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sells Sound Inpatient Physicians Holdings for $2.15 billion 21-Apr-2018 / 14:47 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely res...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks